
Predible Health
AI-powered apps that interpret medical scans for radiologists diagnosing cancer.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
N/A | - | ||
Total Funding | 000k |
Related Content
Predible Health, established in 2016, is a healthcare technology company specializing in AI-driven radiology diagnostics. The company's flagship product, LungIQ, focuses on enhancing the early detection and reporting of lung diseases, including COVID-19 and cancer, by analyzing CT scans. LungIQ integrates seamlessly with all CT scanners and PACS vendors, allowing healthcare providers to install it from any internet-connected workstation. The platform uses deep learning algorithms to detect lung nodules and describe their characteristics such as size, volume, lobe, texture, and calcification, ensuring timely diagnosis and follow-up. Predible Health primarily serves healthcare providers, including hospitals and diagnostic centers, operating in the global healthcare market. The company's business model involves selling its software as a service (SaaS), generating revenue through subscription fees. By leveraging advanced technology, Predible Health aims to address large, unmet clinical needs and improve patient outcomes.
Keywords: AI-driven, radiology diagnostics, CT scans, lung diseases, early detection, deep learning, healthcare technology, SaaS, COVID-19, cancer.